These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37191688)
1. L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson's disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters. Kumar S; Awasthi A; Raj K; Singh S Psychopharmacology (Berl); 2023 Jul; 240(7):1493-1508. PubMed ID: 37191688 [TBL] [Abstract][Full Text] [Related]
2. l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease. Raj K; Gupta GD; Singh S Drug Chem Toxicol; 2022 Sep; 45(5):2097-2108. PubMed ID: 34210222 [TBL] [Abstract][Full Text] [Related]
3. Apigenin Attenuates Functional and Structural Alterations via Targeting NF-kB/Nrf2 Signaling Pathway in LPS-Induced Parkinsonism in Experimental Rats : Apigenin Attenuates LPS-Induced Parkinsonism in Experimental Rats. Patel M; Singh S Neurotox Res; 2022 Aug; 40(4):941-960. PubMed ID: 35608813 [TBL] [Abstract][Full Text] [Related]
4. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway. Jamwal S; Kumar P Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301 [TBL] [Abstract][Full Text] [Related]
5. Effect of Bacille-Calmette-Guerin vaccine against rotenone-induced Parkinson's disease: Role of neuroinflammation and neurotransmitters. Yedke NG; Soni D; Kumar P Fundam Clin Pharmacol; 2024 Jun; 38(3):538-549. PubMed ID: 38041521 [TBL] [Abstract][Full Text] [Related]
6. L-theanine prevent quinolinic acid induced motor deficit and striatal neurotoxicity: Reduction in oxido-nitrosative stress and restoration of striatal neurotransmitters level. Jamwal S; Singh S; Gill JS; Kumar P Eur J Pharmacol; 2017 Sep; 811():171-179. PubMed ID: 28624333 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390 [TBL] [Abstract][Full Text] [Related]
8. Chen CN; Wang MH; Soung HS; Chen SM; Fang CH; Lin YW; Tseng HC Neurotox Res; 2022 Feb; 40(1):241-258. PubMed ID: 34988886 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats. Sharma S; Raj K; Singh S Neurotox Res; 2020 Jan; 37(1):198-209. PubMed ID: 31654381 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics. Deb S; Dutta A; Phukan BC; Manivasagam T; Justin Thenmozhi A; Bhattacharya P; Paul R; Borah A Neurochem Int; 2019 Oct; 129():104478. PubMed ID: 31145971 [TBL] [Abstract][Full Text] [Related]
11. Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: Unrevealing neurochemical and histopathological alterations in rodents. Dhureja M; Deshmukh R Eur J Pharmacol; 2024 Jul; 975():176635. PubMed ID: 38734296 [TBL] [Abstract][Full Text] [Related]
12. Piperine in combination with quercetin halt 6-OHDA induced neurodegeneration in experimental rats: Biochemical and neurochemical evidences. Singh S; Kumar P Neurosci Res; 2018 Aug; 133():38-47. PubMed ID: 29056550 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation. Sharma N; Nehru B Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970 [TBL] [Abstract][Full Text] [Related]
14. l-theanine, the unique constituent of tea, improves neuronal survivability by curtailing inflammatory responses in MPTP model of Parkinson's disease. Deb S; Borah A Neurochem Int; 2024 Oct; 179():105830. PubMed ID: 39128625 [TBL] [Abstract][Full Text] [Related]
15. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation. Gill JS; Jamwal S; Kumar P; Deshmukh R Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592 [TBL] [Abstract][Full Text] [Related]
16. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats. Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220 [TBL] [Abstract][Full Text] [Related]
17. Sun T; Chen L; Liu R; Liu QS; Cheng Y Am J Chin Med; 2023; 51(2):309-328. PubMed ID: 36611142 [TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models. Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238 [TBL] [Abstract][Full Text] [Related]
19. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo. Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997 [No Abstract] [Full Text] [Related]
20. Protective effect of Indole-3-carbinol, an NF-κB inhibitor in experimental paradigm of Parkinson's disease: In silico and in vivo studies. Saini N; Akhtar A; Chauhan M; Dhingra N; Pilkhwal Sah S Brain Behav Immun; 2020 Nov; 90():108-137. PubMed ID: 32800927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]